Lord, Abbett & Co’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-331,134
| Closed | -$20.6M | – | 658 |
|
|
2021
Q2 | $20.6M | Buy |
331,134
+21,815
| +7% | +$1.45M | 0.05% | 412 |
|
|
2021
Q1 | $20.2M | Sell |
309,319
-406
| -0.1% | -$26.5K | 0.05% | 420 |
|
|
2020
Q4 | $20.4M | Sell |
309,725
-8,791
| -3% | -$517K | 0.05% | 409 |
|
|
2020
Q3 | $16.5M | Sell |
318,516
-11,942
| -4% | -$613K | 0.05% | 404 |
|
|
2020
Q2 | $16.3M | Sell |
330,458
-3,761
| -1% | -$203K | 0.06% | 404 |
|
|
2020
Q1 | $17M | Buy |
334,219
+19,031
| +6% | +$1.1M | 0.08% | 343 |
|
|
2019
Q4 | $17.4M | Sell |
315,188
-98,918
| -24% | -$5.37M | 0.06% | 420 |
|
|
2019
Q3 | $20.8M | Sell |
414,106
-507,558
| -55% | -$25.5M | 0.07% | 403 |
|
|
2019
Q2 | $46.5M | Sell |
921,664
-692,377
| -43% | -$33.6M | 0.15% | 236 |
|
|
2019
Q1 | $75M | Buy |
1,614,041
+117,379
| +8% | +$5.95M | 0.25% | 110 |
|
|
2018
Q4 | $73.5M | Sell |
1,496,662
-99,265
| -6% | -$5.65M | 0.27% | 91 |
|
|
2018
Q3 | $99M | Sell |
1,595,927
-578,580
| -27% | -$35.2M | 0.27% | 85 |
|
|
2018
Q2 | $117M | Sell |
2,174,507
-381,229
| -15% | -$19.1M | 0.34% | 47 |
|
|
2018
Q1 | $116M | Buy |
2,555,736
+355,320
| +16% | +$15.2M | 0.35% | 55 |
|
|
2017
Q4 | $86.5M | Sell |
2,200,416
-725,806
| -25% | -$27.6M | 0.25% | 100 |
|
|
2017
Q3 | $108M | Buy |
2,926,222
+356,441
| +14% | +$12.7M | 0.32% | 69 |
|
|
2017
Q2 | $98.9M | Sell |
2,569,781
-116,769
| -4% | -$4.28M | 0.29% | 79 |
|
|
2017
Q1 | $91.5M | Sell |
2,686,550
-1,690,539
| -39% | -$55.5M | 0.27% | 86 |
|
|
2016
Q4 | $144M | Buy |
4,377,089
+41,274
| +1% | +$1.34M | 0.44% | 40 |
|
|
2016
Q3 | $140M | Buy |
4,335,815
+88
| +0% | +$2.85K | 0.43% | 34 |
|
|
2016
Q2 | $134M | Buy |
4,335,727
+365,999
| +9% | +$11.4M | 0.42% | 36 |
|
|
2016
Q1 | $119M | Buy |
3,969,728
+182,700
| +5% | +$5.04M | 0.37% | 49 |
|
|
2015
Q4 | $105M | Sell |
3,787,028
-664,541
| -15% | -$18.9M | 0.32% | 70 |
|
|
2015
Q3 | $136M | Buy |
4,451,569
+2,054,646
| +86% | +$71.5M | 0.41% | 41 |
|
|
2015
Q2 | $87.8M | Buy |
2,396,923
+1,544,048
| +181% | +$55.1M | 0.23% | 110 |
|
|
2015
Q1 | $30.1M | Buy |
852,875
+155,240
| +22% | +$5.31M | 0.08% | 384 |
|
|
2014
Q4 | $21.3M | Sell |
697,635
-64,233
| -8% | -$2M | 0.05% | 457 |
|
|
2014
Q3 | $22.4M | Sell |
761,868
-109,484
| -13% | -$3.34M | 0.06% | 455 |
|
|
2014
Q2 | $24.9M | Sell |
871,352
-149,332
| -15% | -$4.16M | 0.06% | 471 |
|
|
2014
Q1 | $29.2M | Sell |
1,020,684
-145,366
| -12% | -$3.78M | 0.07% | 416 |
|
|
2013
Q4 | $30.9M | Sell |
1,166,050
-192,641
| -14% | -$5.36M | 0.07% | 414 |
|
|
2013
Q3 | $37.3M | Sell |
1,358,691
-915,976
| -40% | -$23.5M | 0.09% | 343 |
|
|
2013
Q2 | $52.1M | Buy |
+2,274,667
| New | +$51.4M | 0.12% | 238 |
|
Other funds holding EHC
JP
TCM
Lord, Abbett & Co's EHC Position: Q3 2021 in Review
Lord, Abbett & Co sold out of Encompass Health (EHC) in Q3 2021, closing a stake of 331,134 shares — an estimated $20.6M sold.
Lord, Abbett & Co first reported a position in EHC in Q2 2013 and held it in 33 quarters. The position peaked at $144M in Q4 2016. 435 funds tracked by Wall St. Rank hold EHC as of Q3 2021.
- Lord, Abbett & Co reported no remaining Encompass Health position as of Q3 2021 after selling out during the quarter.
- Lord, Abbett & Co sold 331,134 Encompass Health shares in Q3 2021, an estimated $20.6M.
- Lord, Abbett & Co first reported a position in Encompass Health in Q2 2013 and held it in 33 quarters.
- Lord, Abbett & Co's Encompass Health position peaked at $144M in Q4 2016.
- 435 funds tracked by Wall St. Rank held Encompass Health as of Q3 2021.
Based on Lord, Abbett & Co's 13F filing for Q3 2021, filed 9 Nov 2021.